Covid-19 was initially detected in late 2019. Since then a growing body of evidence has raised concerns about the ocular complications caused by SARS-CoV-2. The reported ocular manifestations associated with COVID-19 infections vary significantly, including dry eye, conjunctivitis, keratitis, episcleritis, and optic neuropathy.  In the following case report, we establish the possibility of Covid-19 to cause Acute exudative polymorphous vitelliform maculopathy. A 32-year-old woman presented with a history of visual disturbance a few days after she tested positive for COVID-19. Her visual acuity was 6/6 in both eyes at the initial presentation., Slit-lamp examination was unremarkable in both eyes.  : Fundus examination showed bilateral multiple variable-sized posterior pole creamy subretinal yellowish lesions. our case demonstrates the triggering of AEVPM with multifocal subretinal vitelliform deposits shortly after COVID-19 infection. We postulate that this may have resulted from an immunologic mechanism affecting RPE cells, leading to the development of the pockets of subretinal fluid and vitelliform deposits. In the era of a global pandemic, AEPVM may occur in patients with COVID-19 infection.

Mahmoud Eissa has completed his MBBS from Ain Shams university, Cairo, Egypt. I have always been euthanized  about research and covid-19 emerged to the world at the beginning of my medical career which made it more interesting and challenging to understand. I have been working in the UK since 2022. I am currently working as clinical research fellow in ophthalmology. I  have 3 publications all related to covid-19 and infectious disease with one presentation in Infectious disease conference.